TrialCancer medicine2020

Anti-epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma.

Chen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.